Supplier profile
Roche Eesti Osaühing
Every public-sector award we hold for this supplier, across Estonia, from 20 May 2009 to 24 Sept 2026.
Awards won
135
all time
Attributed value
€59.2m
94 shared, unvalued
Buyers
13
public bodies
Active
2009–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Aktsiaselts Ida-Tallinna Keskhaigla | 28 | €6.4m |
| Sihtasutus Tartu Ülikooli Kliinikum | 25 | €11.7m |
| sihtasutus Tartu Ülikooli Kliinikum | 20 | €161k |
| Aktsiaselts Lääne-Tallinna Keskhaigla | 18 | €2.1m |
| Sihtasutus Põhja-Eesti Regionaalhaigla | 17 | €28.6m |
| sihtasutus Põhja-Eesti Regionaalhaigla | 16 | €9.7m |
| Tervisekassa | 3 | not attributable |
| Kaitsevägi | 2 | €17k |
| Sihtasutus Tallinna Lastehaigla | 2 | not attributable |
| Eesti Haigekassa | 1 | not attributable |
What they win
Awards
Showing 1–25 of 135 awards we hold
- Estonia – Pharmaceutical products – Haiglaravimid - september 2026 ↗sihtasutus Põhja-Eesti Regionaalhaiglashared awardawarded 24 Sept 2026
- Estonia – Pharmaceutical products – Mitmesugused ravimid juuni 2026 ↗Aktsiaselts Ida-Tallinna Keskhaiglashared awardawarded 25 Aug 2026
- Estonia – Pharmaceutical products – Faritsimab ↗Aktsiaselts Ida-Tallinna Keskhaiglashared awardawarded 31 Jul 2026
- Estonia – Antineoplastic and immunomodulating agents – Immunosupressantide ja immunostimulaatorite ostmine ↗Aktsiaselts Lääne-Tallinna Keskhaiglashared awardawarded 12 Jun 2026
- Estonia – Antineoplastic agents – Antineoplastilised ravimid ↗sihtasutus Tartu Ülikooli Kliinikumshared awardawarded 26 Mar 2026
- Estonia – Medicinal products for the blood and blood-forming organs – Verejooksu tõkestavad ja aneemiavastased ravimid ↗Aktsiaselts Lääne-Tallinna Keskhaiglashared awardawarded 3 Feb 2026
- Estonia – Pharmaceutical products – Kasvajavastased ained, immunosupressandid, oftalmoloogias kasutatavad ained, hingamisteede obstruktiivsete haiguste raviks kasutatavad ained, migreenivastased ained ↗sihtasutus Põhja-Eesti Regionaalhaiglashared awardawarded 2 Dec 2025
- Estonia – Pharmaceutical products – Totsilizumabi ostmine ↗Tervisekassaawarded 3 Nov 2025
- Estonia – Medical solutions – Silmahaiguste ravis kasutatavad ravimid, lahused ja diagnostilised vahendid ↗sihtasutus Tartu Ülikooli Kliinikumshared awardawarded 31 Oct 2025
- Estonia – Antineoplastic and immunomodulating agents – Antineoplastilised ja immunosupresseerivad ravimid ↗sihtasutus Tartu Ülikooli Kliinikumshared awardawarded 24 Oct 2025
- Estonia – Pharmaceutical products – Meeleelundkonna ravimid (S-grupp) ja oftalmoloogilised lahused ↗Aktsiaselts Ida-Tallinna Keskhaiglashared awardawarded 3 Oct 2025
- Estonia – Pharmaceutical products – Ravim Pertuzumab + trastuzumab L01XY01 subkutaanne süstelahus ↗sihtasutus Tartu Ülikooli Kliinikumshared awardawarded 13 Aug 2025
- Estonia – Pharmaceutical products – Haiglaravimid - juuli 2025 ↗sihtasutus Põhja-Eesti Regionaalhaiglashared awardawarded 24 Jul 2025
- Estonia – Pharmaceutical products – Bevatsizumabi, nab-paklitakseeli ja totsilizumabi ostmine 2025 ↗Tervisekassashared awardawarded 4 Jul 2025
- Estonia – Pharmaceutical products – Tervishoiuteenuste osutamisel kasutatavate ravimite ostmine ↗sihtasutus Tartu Ülikooli Kliinikumshared awardawarded 28 Jun 2025
- Estonia – Pharmaceutical products – B-rühma ravimid ↗sihtasutus Tartu Ülikooli Kliinikumshared awardawarded 19 Jun 2025
- Estonia – Pharmaceutical products – Haiglaravimid - mai 2025 ↗sihtasutus Põhja-Eesti Regionaalhaiglashared awardawarded 7 May 2025
- Estonia – Pharmaceutical products – Antipsühhootilised ained, dermatoloogilised preparaadid, preparaadid köha ja külmetuse leevendamiseks, aneemiavastased preparaadid, perifeerselt toimivad lihaseid lõõgastavad ained 2 ↗sihtasutus Põhja-Eesti Regionaalhaiglashared awardawarded 9 Apr 2025
- Estonia – Pharmaceutical products – Kasvajavastased ja endokrinoloogilised ained (L01-L02) ↗Aktsiaselts Ida-Tallinna Keskhaiglashared awardawarded 4 Apr 2025
- Estonia – Pharmaceutical products – Ravimi Glofitamab (L01FX28) ostmine ↗sihtasutus Tartu Ülikooli Kliinikumshared awardawarded 19 Feb 2025
- Estonia – Pharmaceutical products – Alteplaas, Okrelizumab, Naatriumkloriidi 0,9% loputuslahus , Ibuprofeen ↗Aktsiaselts Ida-Tallinna Keskhaiglashared awardawarded 9 Dec 2024
- Estonia – Pharmaceutical products – Bevatsizumabi, nab-paklitakseeli ja totsilizumabi ostmine ↗Tervisekassashared awardawarded 9 Dec 2024
- Estonia – Pharmaceutical products – Kemoteraapias kasutatavate ravimite ja immuunmodulaatorite ostmine ↗sihtasutus Tartu Ülikooli Kliinikumshared awardawarded 28 Nov 2024
- Estonia – Pharmaceutical products – L04AG08 Ocrelizumab süstelahuse ostmine ↗sihtasutus Tartu Ülikooli Kliinikumshared awardawarded 19 Oct 2024
- Estonia – Pharmaceutical products – Atesolizumab ↗Aktsiaselts Ida-Tallinna Keskhaiglaawarded 17 Sept 2024
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.